Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for July 22nd

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd:

eBay Inc. (EBAY - Free Report) : This commerce platforms operator, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.

eBay Inc. Price and Consensus

eBay Inc. Price and Consensus

eBay Inc. price-consensus-chart | eBay Inc. Quote

eBay has a PEG ratio of 1.57 compared with 2.21 for the industry. The company possesses a Growth Score of B.

eBay Inc. PEG Ratio (TTM)

eBay Inc. PEG Ratio (TTM)

eBay Inc. peg-ratio-ttm | eBay Inc. Quote

Merck & Co., Inc. (MRK - Free Report) :This healthcare solutions provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Merck has a PEG ratio of 1.73, compared with 1.92 for the industry. The company possesses a Growth Score of B.

Magellan Health, Inc. (MGLN - Free Report) : This healthcare management services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

Magellan Health has a PEG ratio of 0.73, compared with 1.35 for the industry. The company possesses a Growth Score of A.

AmerisourceBergen Corporation (ABC - Free Report) : This pharmaceutical products distributor, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

AmerisourceBergen has a PEG ratio of 1.67, compared with 1.75 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>